Levamisole-induced vasculopathy: A systematic review

Seminars in Arthritis and Rheumatism
Anaïs DartevelLuc Mouthon

Abstract

To characterize levamisole-induced vasculopathy. We performed a systematic review searching MEDLINE for articles published from 1972 to 2016. We retrieved 357 references and abstracts and selected 111 articles. Levamisole-induced vasculopathy was reported in 192 patients, with a female predominance (n = 122, 63.5%). Median [interquartile range] age was 44 [38-50]. Skin was the most frequently involved organ (n = 182, 94.8%). Cutaneous lesions were mostly on the face (n = 136, 70.8%), especially the ears. Purpura (n = 131, 68.2%) was the most reported cutaneous lesion. Organ involvement included acute renal failure (n = 24, 12.5%), and pulmonary involvement (n = 20, 10.4%). Anti-neutrophil cytoplasmic antibodies (ANCAs) were found in 167/178 patients (93.8%), with both anti-myeloperoxydase and anti-proteinase 3 specificity reported in 51/118 patients (43.2%). Anti-phospholipid (APL) antibodies were found in 93/137 patients (67.9%). Leukopenia was detected in 69/138 patients (50%). Skin biopsies identified vasculitis and thrombotic vasculopathy in 73/148 (49.3%) and 62/148 (41.9%) patients, respectively. The outcome was favourable in 116/134 patients (86.6%), but relapses were reported in 33 (28.4%), mainly on levamisole re-expos...Continue Reading

References

Aug 1, 1978·Annals of the Rheumatic Diseases·G T WilliamsE C Huskisson
Aug 25, 1999·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·G BarbanoR Gusmano
Jul 28, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·A N C SantanaC S V Barbas
Nov 19, 2009·Harm Reduction Journal·Lewinda KnowlesJames Talbot
Dec 31, 2009·Journal of Analytical Toxicology·Lionel P Raymon, Daniel S Isenschmid
Jul 27, 2010·Autoimmunity Reviews·Peter M Villiger, Loïc Guillevin
Jul 30, 2010·Clinical Pharmacology and Therapeutics·A ChangJ Thomas
Mar 29, 2011·Journal of Analytical Toxicology·Kara L LynchAlexander H Kral
Apr 28, 2011·JAMA : the Journal of the American Medical Association·Jennie A BuchananRichard Dart
May 3, 2011·Journal of Pharmaceutical and Biomedical Analysis·Elisabetta BertolSteven B Karch
Oct 19, 2011·Journal of Analytical Toxicology·Michael L TrehyRong-Jen Hwang
Mar 30, 2012·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Alexandre Larocque, Robert S Hoffman
Aug 10, 2012·Current Rheumatology Reports·Luis R Espinoza, Rodolfo Perez Alamino
Sep 4, 2012·Autoimmunity Reviews·M TrimarchiU Specks
Jan 11, 2013·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Hanan A AlmouhawisStephen R Porter
Jun 13, 2013·Psychosomatics·Carolyn AuffenbergNehama Dresner
Jun 14, 2013·Clinical Reviews in Allergy & Immunology·Will TsengTimothy E Albertson
Oct 23, 2013·Chemico-biological Interactions·Bruno Mégarbane, Lucie Chevillard
Jan 21, 2014·Neuropharmacology·Christopher S TallaridaScott M Rawls
Jun 17, 2014·Rhinology·M TrimarchiM Bussi
Nov 5, 2014·Journal of Psychoactive Drugs·Céline EidenHélène Peyrière
Mar 11, 2015·Journal of Forensic Sciences·Marek DziadoszJörg Teske
May 31, 2016·The International Journal on Drug Policy·Fernando CaudevillaNuria Calzada

❮ Previous
Next ❯

Citations

Mar 8, 2020·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·Matthew L Coates, Marcos Martinez Del Pero
Mar 30, 2020·Ophthalmic Plastic and Reconstructive Surgery·Hannah M Muniz CastroKarina Richani
Aug 12, 2019·Rheumatology International·Fabian LötscherIna Kötter
Apr 9, 2020·The New England Journal of Medicine·Jeffrey S BernsMelis N Anahtar
Aug 28, 2020·SAGE Open Medical Case Reports·Alexandre LemieuxChantal Bolduc
Sep 4, 2019·Journal of the American Academy of Dermatology·Corey GeorgesenJoanna Harp
Sep 4, 2019·Journal of the American Academy of Dermatology·Corey GeorgesenJoanna Harp
Jan 3, 2021·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·Rupert PhillipsKimberley Allan
Mar 6, 2021·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Federica ZottaFrancesco Emma
Oct 3, 2018·ACS Chemical Neuroscience·Julian MaierHarald H Sitte
Aug 27, 2021·International Journal of Dermatology·Chung-Hao Hsu, Tsu-Man Chiu

Jul 15, 2020·La Revue de médecine interne·Félix BlaisonPierre Duffau
Nov 23, 2021·Archives of Dermatological Research·Catherine K KeimRajendra Kapila

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.